Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.86 USD | -0.06% | +8.08% | +13.23% |
18/04 | Alx Oncology Holdings Insider Sold Shares Worth $710,195, According to a Recent SEC Filing | MT |
10/04 | ALX Oncology Reports Positive Data From Ongoing Phase 1/2 Trial of Evorpacept | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 851M 70.99B |
---|---|---|---|---|---|
Net income 2024 * | -173M -14.42B | Net income 2025 * | -171M -14.26B | EV / Sales 2024 * | - |
Net Debt 2024 * | 952K 79.37M | Net Debt 2025 * | 13.89M 1.16B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.15
x | P/E ratio 2025 * |
-5.97
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.14% |
Latest transcript on ALX Oncology Holdings Inc.
1 day | -0.06% | ||
1 week | +8.08% | ||
Current month | +51.21% | ||
1 month | +50.67% | ||
3 months | +14.38% | ||
6 months | +143.64% | ||
Current year | +13.23% |
Managers | Title | Age | Since |
---|---|---|---|
Jaume Pons
FOU | Founder | 58 | 01/15/01 |
Jason Lettmann
CEO | Chief Executive Officer | 46 | 01/20/01 |
Peter García
DFI | Director of Finance/CFO | 62 | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 28/22/28 |
Corey Goodman
CHM | Chairman | 72 | 01/15/01 |
Jack Nielsen
BRD | Director/Board Member | 60 | 01/20/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +6.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 16.86 | -0.06% | 466,719 |
25/24/25 | 16.87 | +4.01% | 509,819 |
24/24/24 | 16.22 | +4.65% | 441,585 |
23/24/23 | 15.5 | +8.92% | 443,830 |
22/24/22 | 14.23 | -8.78% | 287,330 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.23% | 851M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ALXO Stock